Resveratrol in cell fate decisions

Journal of Bioenergetics and Biomembranes

Volumn 39, Issue 1, 2007, Pages 59-63

  Holme, Andrea Lisa ^a   Pervaiz, Shazib ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Apoptosis; Mitochondria; Resveratrol; ROS

Indexed keywords

INSULIN; RESVERATROL;

ANTINEOPLASTIC ACTIVITY; BIOENERGY; CANCER INHIBITION; CARCINOGENESIS; CELL FATE; CELL GROWTH; CELL SURVIVAL; CHEMOPROPHYLAXIS; HEART PROTECTION; HUMAN; INSULIN RESISTANCE; MITOCHONDRIAL MEMBRANE; NEUROPROTECTION; NONHUMAN; OBESITY; ORIENTAL MEDICINE; POLYGONATUM; RESPIRATORY CHAIN; SHORT SURVEY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL SURVIVAL; ELECTRON TRANSPORT; ENERGY METABOLISM; HUMANS; MITOCHONDRIA; REACTIVE OXYGEN SPECIES; STILBENES;

VITACEAE;

EID: 34249940250     PISSN: 0145479X     EISSN: 15736881     Source Type: Journal    
DOI: 10.1007/s10863-006-9053-y     Document Type: Short Survey

References (56)

1. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y (2004) Anticancer Res 24:2783-840
2. Aggarwal BB, Shishodia S (2006) Biochem Pharmacol 71:1397-1421
3. Ahmad KA, Clement MV, Hanif IM, Pervaiz S (2004) Cancer Res 64:1452-1459
4. Ahmad KA, Clement MV, Pervaiz S (2003) Ann N Y Acad Sci 1010:365-373
5. Alves NL, van Lier RA, Eldering E (2006) Trends Immunol
6. Aziz MH, Nihal M, Fu VX, Jarrard DF, Ahmad N (2006) Mol Cancer Ther 5:1335-1341
7. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA (2006) Nature
8. Baur JA, Sinclair DA (2006) Nat Rev Drug Discov 5:493-506
9. Bhat KP, Pezzuto JM (2002) Ann N Y Acad Sci 957:210-229
10. Cahuzac N, Baum W, Kirkin V, Conchonaud F, Wawrezinieck L, Marguet D, Janssen O, Zornig M, Hueber AO (2006) Blood 107:2384-2391
11. Cheng WC, Berman SB, Ivanovska I, Jonas EA, Lee SJ, Chen Y, Kaczmarek LK, Pineda F, Hardwick JM (2006) Oncogene 25:4697-4705
12. Chipuk JE, Bouchier-Hayes L, Green DR (2006) Cell Death Differ 13:1396-1402
13. Clement MV, Hirpara JL, Chawdhury SH, Pervaiz S (1998) Blood 92:996-1002
14. Clement MV, Hirpara JL, Pervaiz S (2003) Cell Death Differ 10:1273-1285
15. Cosgrove MS, Bever K, Avalos JL, Muhammad S, Zhang X, Wolberger C (2006) Biochemistry 45:7511-7521
16. Cuendet M, Pezzuto JM (2000) Drug Metabol Drug Interact 17:109-157
17. Dimanche-Boitrel MT, Meurette O, Rebillard A, Lacour S (2005) Drug Resist Updat 8:5-14
18. Faber AC, Dufort FJ, Blair D, Wagner D, Roberts MF, Chiles TC (2006) Biochem Pharmacol 72:1246-1256
19. Fulda S, Debatin KM (2005) Eur J Cancer 41:786-798
20. Galonek HL, Hardwick JM (2006) Nat Cell Biol 8:1317-1319
21. Gautam SC, Xu YX, Dumaguin M, Janakiraman N, Chapman RA (2000) Bone Marrow Transplant 25:639-645
22. Gosslau A, Chen M, Ho CT, Chen KY (2005) Br J Cancer 92:513-521
23. Green DR, Kroemer G (2004) Science 305:626-629
24. Henkler F, Behrle E, Dennehy KM, Wicovsky A, Peters N, Warnke C, Pfizenmaier K, Wajant H (2005) J Cell Biol 168:1087-1098
25. Ingram DK, Zhu M, Mamczarz J, Zou S, Lane MA, Roth GS, de Cabo R (2006) Aging Cell 5:97-108
26. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM (1997) Science 275:218-220
27. Kolthur-Seetharam U, Dantzer F, McBurney MW, de Murcia G, Sassone-Corsi P (2006) Cell Cycle 5:873-877
28. Kopp P (1998) Eur J Endocrinol 138:619-620
29. Kubo M, Kimurta Y, Shin H, Haneda T, Tani T, Namba K (1981) Shoyakugaku Zasshi 35:58-61
30. Kundu JK, Chun KS, Kim SO, Surh YJ (2004) Biofactors 21:33-39
31. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J (2006) Cell
32. Langcake P, Pryce RJ (1976) Physiol Plant Pathol 9:77-86
33. Lee SC, Chan J, Clement MV, Pervaiz S (2006) Proteomics 6:2386-2394
34. Leibiger IB, Berggren PO (2006) Nat Med 12:34-36; discussion 36
35. Longo VD, Kennedy BK (2006) Cell 126:257-68
36. Lu J, Ho CH, Ghai G, Chen KY (2001) Carcinogenesis 22:321-328
37. Mahyar-Roemer M, Kohler H, Roemer K (2002) BMC Cancer 2:27
38. Murias M, Handler N, Erker T, Pleban K, Ecker G, Saiko P, Szekeres T, Jager W (2004) Bioorg Med Chem 12:5571-5578
39. Nonomura S, Kanagawa H, Makimoto A (1963) Yakugaku Zasshi 83:988-990
40. Ou HC, Chou FP, Sheen HM, Lin TM, Yang CH, Huey-Herng Sheu W (2006) Clin Chim Acta 364:196-204
41. Pervaiz S (2003) Faseb J 17:1975-1985
42. Pervaiz S (2004) Drug Resist Updat 7:333-344
43. Pervaiz S, Cao J, Chao OS, Chin YY, Clement MV (2001) Oncogene 20:6263-6268
44. Pervaiz S, Ramalingam JK, Hirpara JL, Clement MV (1999) FEBS Lett 459:343-348
45. Poolman TM, Ng LL, Farmer PB, Manson MM (2005) Free Radic Biol Med 39:118-132
46. Sexton E, Van Themsche C, Leblanc K, Parent S, Lemoine P, Asselin E (2006) Mol Cancer 5:45
47. Siemann EH, Creasy LL (1992) An J Eno Vitic 43:49-52
48. Soleas GJ, Diamandis EP, Goldberg DM (1997) Clin Biochem 30:91-113
49. Su JL, Lin MT, Hong CC, Chang CC, Shiah SG, Wu CW, Chen ST, Chau YP, Kuo ML (2005) Carcinogenesis 26:1-10
50. Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, Lee SS (2001) Mutat Res 480-481:243-268
51. Tang HY, Shih A, Cao HJ, Davis FB, Davis PJ, Lin HY (2006) Mol Cancer Ther 5:2034-2042
52. Velthuis JH, Rouschop KM, De Bont HJ, Mulder GJ, Nagelkerke JF (2002) J Biol Chem 277:24631-24637
53. Wang Y, Wang B, Cheng J, Yang L, Liu ZL, Balan K, Pantazis P, Wyche JH, Han Z (2005) Biochem Pharmacol 69:249-254
54. Ying W (2006) Front Biosci 11:3129-3148
55. Zheng J, Ramirez VD (1999) Biochem Biophys Res Commun 261:499-503
56. Zheng J, Ramirez VD (2000) Br J Pharmacol 130:1115-1123